New Drug Could Reduce Peanut Allergies

A new drug treatment could reduce and possibly cure peanut allergies.

Tanax Pharmaceuticals, the drug developer says the drug, called TNX-901, works by neutralising antibodies that set off severe allergic reactions.

Michelle DeSantis, of Tanax Pharmaceuticals, explains ‘In the study, 84 people suffering from immediate hypersensitivity to peanuts  were given TNX-901 or a placebo every month for four months. The level at which peanuts triggered allergic reactions rose, on average,  from around half a peanut to almost nine peanuts – which should give a  significant protection from most exposures.’

The research showed that a person who might previously have suffered a severe reaction – often breathing difficulties requiring immediate medical treatment – from eating a food containing three or four peanuts might get away with a little itching and inflammation.

In Britain, where the drug will soon be assessed in trials, TNX-901 could be available in as little as two years.

Speak Your Mind


INFORMATION on IS NOT MEDICAL ADVICE and any information or materials posted are intended for general informational purposes only. Any information posted on the web site is NOT a substitute for medical attention. Please see your health-care professional for medical advice and treatment.